Ultrasound in symptoms of acute scrotum assessed in Swedish Skåne Region

23

Oct 2019

In Sweden, Skåne Region develops the knowledge base and prepares questions for decisions on the introduction of evidence-based health and medical care throughout Region Skåne. The medical evaluations are conducted in accordance with the principles for critical review of published scientific literature used by the National Board of Health and Social Evaluation.

In September 2019, Skåne Region has released a report for ultrasound in symptoms of the acute scrotum that aimed to understand whether increased use of ultrasound could improve the diagnostic of the studied condition. The following conclusions were provided:

  • A literature review shows that there are no studies investigating the direct benefit of ultrasound in patients with symptoms of acute scrotum. However, high precision, sensitivity, and specificity of the method are outlined
  • Current HTA report shows that changes in ultrasound use would mean an increase of the number of examinations that would lead to further need in the rise of the access to ultrasound out of hours
  • An introduction of the method into routine practice should be followed by the simultaneous systematic establishment of a specific clinical scoring system

See the full information in Swedish here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

23

Mar 2022

In late January 2022, Swedish Medical Technologies Product (MTP) Council issued an updated version of recommendations regarding gene expression analysis for decision-making on the adjuvant breast cancer treatment, initially published in November 2021. The recommendation to the regions remains the same. The changes were only concerned with the clarification of some facts.

Read more

16

Mar 2022

In February 2022, Swedish Medical Technologies Product (MTP) Council issued an updated recommendation on FreeStyle Libre for continuous glucose monitoring in type 2 diabetes (T2D). The initial recommendations were published by NT Council in 2018 and updated by MTP Council in 2020 to include FreeStyle Libre 2. In the 2022 update, MTP Council decreased the Hba1c limit from 70 to 60 mmol/mol and added a statement on lifestyle changes and treatment optimization with non-insulin antidiabetic drugs.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

Read more